-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Pharvaris, Lowers Price Target to $51

Benzinga·04/06/2026 13:16:48
Listen to the news
RBC Capital analyst Brian Abrahams maintains Pharvaris (NASDAQ:PHVS) with a Outperform and lowers the price target from $52 to $51.